Muscle Invasive Bladder Cancer: Clinical Trials

1 completed. 1 Phase 1.

By phase and status

Phase	Trials	Status
Phase 1	1	Completed 1

Follow Muscle Invasive Bladder Cancer: new trials by email Literature Review of Muscle Invasive Bladder Cancer trials Research Report on Muscle Invasive Bladder Cancer

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Feasibility Study of Durvalumab +/- Oleclumab as Neoadjuvant Therapy for Muscle-invasive Bladder Cancer (BLASST-2) Durvalumab, Oleclumab - Muscle Invasive Bladder Cancer	Phase 1	Completed	Dana-Farber Cancer Institute	12	2019-02-20	2022-09-13

Narrower conditions

Urinary Bladder Neoplasms (1)

Broader conditions

Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Male Urogenital Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Urinary Bladder Diseases (1)  ·  Urogenital Diseases (1)  ·  Urogenital Neoplasms (1)  ·  Urologic Diseases (1)  ·  Urologic Neoplasms (1)

Interventions

durvalumab (1)

Sponsors

Dana-Farber Cancer Institute (1)

Countries

United States (1)

Top investigators

Xiao X Wei, MD (1)